Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Authors
Posts by Firstwordpharma News
Firstwordpharma News
1080 POSTS
0 COMMENTS
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application...
Firstwordpharma News
-
July 18, 2019
0
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for...
Firstwordpharma News
-
July 18, 2019
0
Deals
Spring Bank Announces Research Agreement with The National Institute of Allergy...
Firstwordpharma News
-
July 18, 2019
0
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for...
Firstwordpharma News
-
July 18, 2019
0
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial...
Firstwordpharma News
-
July 18, 2019
0
1
2
3
...
216
Page 1 of 216
- Advertisement -
MOST POPULAR
Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio...
April 1, 2019
Verve Therapeutics Explodes out of Stealth Mode to Focus on Gene...
May 7, 2019
Hikma launches Abiraterone Acetate Tablets
February 14, 2019
Jury Awards Plaintiffs $2 Billion in Roundup Case, Bayer Will Appeal
May 14, 2019
Load more
HOT NEWS
Commercial
Anaveon, a new Immuno-Oncology company, announces CHF 35 million Series A...
Deals
Gilead Forges NASH Deal With insitro as It Continues to Take...
Phase II
Achieve Life Sciences Announces Completion of Enrollment in 254-Subject Phase 2b...
Commercial
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results...
